Hjem › Multipel sklerose › Maryland
Multipel sklerose kliniske forsøg i Maryland
17 studier for Multipel sklerose søger deltagere på steder i Maryland.
Byer i Maryland
Officiel studietekst (engelsk)
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1/2
Alder 18 til 120 · Alle køn · Opdateret 2. okt. 2026 · NCT03109288Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
1 Month – 99 Years · Alle køn · Opdateret 2. okt. 2026 · NCT00794352Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Baltimore
- TG Therapeutics Investigational Trial Site, Glen Burnie
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT06433752Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 2
Alder 18 til 120 · Alle køn · Opdateret 16. sep. 2026 · NCT02784210Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 til 120 · Alle køn · Opdateret 16. sep. 2026 · NCT00001248RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Sunstone Therapies, PC, Rockville
- Sheppard Pratt, Towson
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 15. sep. 2026 · NCT07002034Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Baltimore Veterans Affairs Medical Center- Site Number : 8400163, Baltimore
RekruttererFase 3
Alder 18 til 60 · Alle køn · Opdateret 15. sep. 2026 · NCT07325292Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 2 til 120 · Alle køn · Opdateret 31. aug. 2026 · NCT01730131A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Mid Atlantic Epilepsy and Sleep Ctr, Bethesda
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 29. jul. 2026 · NCT07225504Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
- Johns Hopkins University, Baltimore
RekruttererFase 2
Alder 18 til 60 · Alle køn · Opdateret 17. jul. 2026 · NCT07497399Solriamfetol for the Treatment of Multiple Sclerosis Fatigue
- Johns Hopkins University, Baltimore
RekruttererFase 2
Alder 18 til 60 · Alle køn · Opdateret 9. jun. 2026 · NCT06170970Pathological Basis of MRI Signal Changes in Multiple Sclerosis
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 til 120 · Alle køn · Opdateret 5. jun. 2026 · NCT02659956Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1
Alder 18 til 120 · Alle køn · Opdateret 5. jun. 2026 · NCT05849467Genes and Environment in Multiple Sclerosis
- National Institute of Neurological Disorders and Stroke, Bethesda
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 14. maj 2026 · NCT01353547Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis
- Johns Hopkins University, Baltimore
RekruttererFase 4
Alder 18 til 65 · Alle køn · Opdateret 6. maj 2026 · NCT07389590A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
- Evidera INC., Bethesda
- Evidera, Bethesda
RekruttererObservationsstudie
Alle aldre · Kvinder · Opdateret 20. nov. 2025 · NCT05170126Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.